Indication
Diabetes mellitus with severe insulin resistance
Diabetes mellitus with severe insulin resistance is an endocrine and metabolic disorder characterized by persistent hyperglycemia arising from a profound impairment in target tissue responsiveness to insulin. Read more about Diabetes mellitus with severe insulin resistance
3 drugs 1 manufacturers
Drugs that treat it
Common Diabetes mellitus with severe insulin resistance therapies.
HUMULIN R U-500 KWIKPEN (insulin regular, human)
HUMULIN R U-500 (CONC) KWIKPEN (insulin regular, human)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiabetes mellitus with severe insulin resistance is an endocrine and metabolic disorder characterized by persistent hyperglycemia arising from a profound impairment in target tissue responsiveness to insulin.
Primarily affecting metabolic tissues including skeletal muscle, adipose tissue, and the liver, this clinical state occurs either as an extreme presentation of type 2 diabetes—often exacerbated by profound obesity—or secondary to rare genetic or autoimmune conditions such as lipodystrophy syndromes, insulin receptor mutations, or anti-insulin receptor antibodies.
It is clinically defined by marked endogenous hyperinsulinemia or exceptionally high exogenous insulin requirements, commonly exceeding 2 units per kilogram per day or 200 units daily, and frequently manifests with severe acanthosis nigricans, pronounced dyslipidemia, and hepatic steatosis.
- nih.gov
Diabetes mellitus with severe insulin resistance is an endocrine and metabolic disorder characterized by persistent hyperglycemia arising from a profound impairment in target tissue responsiveness to insulin Primarily affecting metabolic tissues including skeletal muscle, adipose tissue, and the liver, this clinical state occurs either as an extreme presentation of type 2 diabetes—often exacerbated by profound obesity—or secondary to rare genetic or autoimmune conditions such as lipodystrophy sy...
- nih.gov
Diabetes mellitus with severe insulin resistance is an endocrine and metabolic disorder characterized by persistent hyperglycemia arising from a profound impairment in target tissue responsiveness to insulin Primarily affecting metabolic tissues including skeletal muscle, adipose tissue, and the liver, this clinical state occurs either as an extreme presentation of type 2 diabetes—often exacerbated by profound obesity—or secondary to rare genetic or autoimmune conditions such as lipodystrophy sy...
- jci.org
Primarily affecting metabolic tissues including skeletal muscle, adipose tissue, and the liver, this clinical state occurs either as an extreme presentation of type 2 diabetes—often exacerbated by profound obesity—or secondary to rare genetic or autoimmune conditions such as lipodystrophy syndromes, insulin receptor mutations, or anti-insulin receptor antibodies
- cuh.nhs.uk
It is clinically defined by marked endogenous hyperinsulinemia or exceptionally high exogenous insulin requirements, commonly exceeding 2 units per kilogram per day or 200 units daily, and frequently manifests with severe acanthosis nigricans, pronounced dyslipidemia, and hepatic steatosis
- medlineplus.gov
It is clinically defined by marked endogenous hyperinsulinemia or exceptionally high exogenous insulin requirements, commonly exceeding 2 units per kilogram per day or 200 units daily, and frequently manifests with severe acanthosis nigricans, pronounced dyslipidemia, and hepatic steatosis
Personalize your experience
Follow Diabetes mellitus with severe insulin resistance and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.